What would it take to get peptides on the shelf?

An FDA advisory panel's recent decision to approve certain popular peptides has sparked significant interest in this emerging market, highlighting both potential benefits and risks. The vote has raised questions about the regulation of these products, as the current supply is largely unregulated. This move could lead to more peptides becoming available to consumers, but it also underscores the need for stricter oversight to ensure safety and efficacy, given the potential health implications. The debate now centers on how to balance innovation with consumer protection.